期刊文献+

乳腺癌新辅助化疗前后病理组织学的变化 被引量:3

Histopathological changes of breast cancer after neoadjuvant chemotherapy
下载PDF
导出
摘要 目的观察乳腺癌新辅助化疗前后的病理组织学改变。方法选择经粗针穿刺确诊的乳腺癌患者56例,采用FEC方案行新辅助化疗,完成2-3周期后再行手术治疗。手术后通过肿瘤分级、肿瘤坏死、炎细胞浸润、间质出血、纤维化等指标对化疗前后组织学标本进行比较评价。结果新辅助化疗后肿瘤完全消失1例,肿瘤实质细胞呈不同程度的蜕变,如肿瘤细胞坏死、原位癌结构形成、瘤巨细胞形成、肿瘤细胞胞浆空泡化。间质变化包括间质水肿、坏死、出血、玻璃样变性、钙化、纤维化和炎细胞浸润等。结论新辅助化疗不仅产生肿瘤细胞的坏死,也可导致瘤巨细胞形成。新辅助化疗对肿瘤间质也有明显的影响。 Objective To evaluate histopathological changes of breast cancer after neoadjuvant chemotherapy. Methods Evaluation of histopathological changes was carried out restrospectively in 56 patients with breast cancer who undertook neoadjuvant chemotherapy. The diagnosis of breast cancer was identified by core needle biopsies before chemotherapy. All patients received neoadjuvant FEC chemotherapy for 2 to 3 cycles followed by mastectomy or conserving-breast surgery. The histopathalogical changes were compared between the pre- and post-chemotherapy specimens based on necrosis, edema, inflammatory infiltrate, bleeding, fibrosis in tumor. Results One patient got complete pathologic response that the tumor disappeared. A significant histopathologic changes including necrosis, giant epithelial tumor cells, ductal carcinoma in situ and cytoplasmic vacuolation in tumor ceils were observed after neoadjuvant chemotherapy as well as edema, necro- sis, fibrosis, hyaline degeneration, inflammatory infiltrate in interstitium. Conclusions Neoadjuvant chemotherapy resulted in not only parenchymatous changes such as necrosis, giant epithelial tumor cells, but also interstitial part changes in breast cancer.
出处 《山东医药》 CAS 北大核心 2009年第40期22-24,共3页 Shandong Medical Journal
关键词 乳腺肿瘤 抗肿瘤联合化疗方案 病理学 breast neoplasms antineoplastic combined chemotherapy protocols pathology
  • 相关文献

参考文献7

  • 1Gralow JR, Burstein HI, Wood W, et al. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease [ J ]. J Clin Oncol, 2008,26 ( 5 ) : 814- 819.
  • 2吴秀萍,谢源福.局部晚期乳腺癌新辅助化疗48例初探并文献复习[J].临床医药实践,2004,13(6):436-438. 被引量:4
  • 3Rajah R, Esteva FJ, Symmans WF. Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response [ J ]. Clin Breast Cancer, 2004,5 ( 3 ) : 235-238.
  • 4Sassen S, Fend F, Avril N. Histopathologic and metabolic criteria for assessment of treatment response in breast cancer [ J ]. PET Clin, 2005,1 ( 1 ) : 83-94.
  • 5周士福,费伯健,金留根.新辅助化疗对乳腺癌组织学分级和ER、p53、C-erbB-2、Ki-67表达的影响[J].江苏医药,2005,31(12):906-908. 被引量:2
  • 6Adams AL, Eltoum I, Krontiras H, et al. The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma [ J ]. Breast J, 2008,14 (2) : 141-146.
  • 7Moreno A, Escobedo A, Benito E, et al. Pathologic changes related to CMF primary chemotherapy in breast cancer [ J]. Breast Cancer Res Treat, 2002, 75(2) : 119-125.

二级参考文献17

  • 1徐玉秀,徐文怀,唐淑萍.乳癌围手术期化疗与切口愈合的关系(附29例临床分析)[J].中国实用外科杂志,1994,14(6):354-355. 被引量:10
  • 2李力军,刘春燕,杜伟生,王玲娟,连正杰,张文莉,范洁,崔永旺,郭怡辉,汪金钟.Ⅲ期乳腺癌的新辅助化疗[J].中国肿瘤临床,1995,22(4):248-251. 被引量:11
  • 3Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology,1999,19:403-410.
  • 4Susan H, Lee MD, Maureen A, et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer. Am J Surg, 2003,186: 348-350.
  • 5Faneyte IF,Schrama JG,Peterse JL, et al. Breast cancer response to neoadjuvant chemotherapy., predictive markers and relation with outcome. British journal of Cancer, 2003,88 : 406-412.
  • 6Petit T, Borel C, Ghnassia JP, et al. Chemotherapy response of breast cancer depends on C-erbB-2 status and anthreacycline dose intensity in the neoadjuvant setting. Clinical Cancer Research,2001,7: 1577-1581.
  • 7Geisler S, Lonning PE, Aas T, et al. Influence of p53 gene alterations and c-erbB-2 expression on the response on the response to treatment with doxorubicin in locally advance breast cancer.Cancer Res, 2001,61 : 2505-2512.
  • 8江泽飞,宋三泰,徐建明,刘晓晴,李家益,李彦博.局部晚期乳癌新辅助化疗(附5例临床报告)[J].中国实用外科杂志,1997,17(12):717-718. 被引量:16
  • 9李俊,沈坤炜,韩企夏,沈镇宙.乳腺癌新辅助化疗的回顾性研究[J].中国癌症杂志,1998,8(3):175-178. 被引量:4
  • 10韩企夏.乳腺癌新辅助化疗进展[J].中国普外基础与临床杂志,1998,5(5):296-297. 被引量:6

共引文献4

同被引文献17

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部